Global Transdermal Drug Patches Market By Type (Fentanyl Transdermal Patch, Nicotine Transdermal Patch, and Others), By Application (Used for Hypertension, Used for Contraception, and Others), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 134794
- 12-Dec
- PDF/PPT/Word
-
Report Details
The report on Transdermal Drug Patches Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global transdermal drug patches market is segmented on the basis of Type, Application and geography.
The global Transdermal Drug Patches market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.
Transdermal Drug Patches Market Scope:
By type, the market is segmented into Fentanyl Transdermal Patch, Nicotine Transdermal Patch, Buprenorphine Transdermal Patch, Clonidine Transdermal Patch and Oxybutynin Transdermal Patch. By Application, the market is divided into Used for Hypertension, Used for Contraception, Used for Analgesia, Used for Smoking Cessation, Used for Angina and Used for Hormone Replacement. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. Major players profiled in the report include Noven, Mylan, Novartis, Johnson & Johnson, Agile Therapeutics, Teikoku Pharma USA, Immune Pharmaceuticals, Hercon Pharmaceuticals, Pocono, DURECT Corporation?and Xel Pharmaceuticals.
Key Market Segments
Type
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal PatchApplication
Used for Hypertension
Used for Contraception
Used for Analgesia
Used for Smoking Cessation
Used for Angina
Used for Hormone ReplacementKey Market Players included in the report:
Noven
Mylan
Novartis
Johnson & Johnson
Agile Therapeutics
Teikoku Pharma USA
Immune Pharmaceuticals
Hercon Pharmaceuticals
Pocono
DURECT Corporation
Xel PharmaceuticalsReasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Transdermal Drug Patches Market share analysis of high players, along with company profiles and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Transdermal Drug Patches Market, high-growth regions, and market drivers, restraints and also market chances.
The analysis covers Transdermal Drug Patches Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Transdermal Drug Patches Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Transdermal Drug Patches Market together side their company profiles, SWOT analysis, latest advancements and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers and industry-specific challenges and risks).
To know the Transdermal Drug Patches Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Transdermal Drug Patches sub-markets, depending on key regions (various vital states).
To analyze Transdermal Drug Patches Market concerning growth trends, prospects and also their participation in the entire sector.
To examine and study the Transdermal Drug Patches Market size (volume & value) from the company, essential regions/countries, products and Application, background information from 2012 to 2018 and also prediction to 2028.
Primary worldwide Transdermal Drug Patches Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches and acquisitions on the market. -
Table Of Content
1. Transdermal Drug Patches Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Transdermal Drug Patches Market Overview3.1. Transdermal Drug Patches Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Manufacturer Intensity Map4. Global Transdermal Drug Patches Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-20284.1. Global Transdermal Drug Patches Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Fentanyl Transdermal Patch
4.4. Nicotine Transdermal Patch
4.5. Buprenorphine Transdermal Patch
4.6. Clonidine Transdermal Patch
4.7. Oxybutynin Transdermal Patch5. Global Transdermal Drug Patches Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-20285.1. Global Transdermal Drug Patches Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Used for Hypertension
5.4. Used for Contraception
5.5. Used for Analgesia
5.6. Used for Smoking Cessation
5.7. Used for Angina
5.8. Used for Hormone Replacement6. Global Transdermal Drug Patches Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-20286.1. North America
6.1.1. North America Transdermal Drug Patches Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2. Europe
6.2.1. Europe Transdermal Drug Patches Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Transdermal Drug Patches Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia6.4. Latin America
6.4.1. Latin America Transdermal Drug Patches Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Transdermal Drug Patches Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA
7. Global Transdermal Drug Patches Market Competitive Landscape, Market Share Analysis, and Company Profiles7.1. Market Share Analysis
7.2. Company Profiles
7.3. Noven7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments7.4. Mylan7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments7.5. Novartis7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments7.6. Johnson & Johnson7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments7.7. Agile Therapeutics7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments7.8. Teikoku Pharma USA7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments7.9. Immune Pharmaceuticals7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments7.10. Hercon Pharmaceuticals7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments7.11. Pocono7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments7.12. DURECT Corporation7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments7.13. Xel Pharmaceuticals7.13.1. Company Overview
7.13.2. Financial Highlights
7.13.3. Product Portfolio
7.13.4. SWOT Analysis
7.13.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample
